ONCY

Oncolytics Biotech Inc

• PUBT·6d ago

  Oncolytics Biotech COO John Bearden McAdory files initial beneficial ownership statement

• PUBT·6d ago

  Oncolytics Biotech director Stephen C. Glover files initial beneficial ownership statement

• TipRanks·06/02 13:33

  Oncolytics Biotech Strengthens Leadership with New COO, Director

• Benzinga·06/02 13:05

  Oncolytics Biotech Promotes John McAdory To COO

• PUBT·06/02 13:03

  Oncolytics Biotech names Steve Glover to board of directors

• Dow Jones·06/02 13:00

  Press Release: Oncolytics Biotech(R) Announces Appointment of Steve Glover to Board of Directors and Promotion of John McAdory to Chief Operating Officer

• TipRanks·06/01 14:25

  Oncolytics Biotech (ONCY) Gets a Buy from Lake Street

• TipRanks·06/01 13:55

  Oncolytics Highlights Pelareorep-RAS Combo Preclinical Cancer Results

• TipRanks·06/01 13:47

  Oncolytics announces initial data from pelareorep combination study

• Benzinga·06/01 13:08

  Oncolytics Biotech Announces Initial Data From Preclinical Study Supporting Further Evaluation Of Pelareorep In Combination With RAS Inhibitor Modalities In Solid Tumor Model

• PUBT·06/01 13:02

  Oncolytics Biotech reports positive preclinical data for pelareorep with RAS-targeted therapies in solid tumor model

• TipRanks·05/26 10:30

  Analysts Offer Insights on Healthcare Companies: CervoMed (CRVO), Bicara Therapeutics Inc. (BCAX) and Oncolytics Biotech (ONCY)

• Dow Jones·05/26 10:26

  Oncolytics Biotech Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

• Benzinga·05/26 10:16

  HC Wainwright & Co. Reiterates Buy on Oncolytics Biotech, Maintains $10 Price Target

• TipRanks·05/22 13:45

  Oncolytics Biotech to present data at ASCO 2026 on pelareorep